Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Beluga Health vs BloomWell Rx

Beluga Health
Graded #430

Lower grade

vs+5.5
BloomWell Rx
Graded #296

Higher grade

The verdict

BloomWell Rx takes it — 61.3/100 to 55.8/100.

BloomWell Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BloomWell Rx is a 100% online telehealth service offering personalized compounded GLP-1 weight loss — semaglutide (from $199/mo) and tirzepatide/GLP-1+GIP (from $249/mo) — after a free visit, plus wellness…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBloomWell Rx +9
45
54
Dose & formulationBloomWell Rx +24
40
64
Clinical oversightBeluga Health +5
76
71
Labs & monitoringBeluga Health +9
62
53
FulfillmentBloomWell Rx +6
64
70
Contract termsEven
55
55
Beluga Health · left barBloomWell Rx · right bar

The numbers

MetricBeluga HealthBloomWell Rx
WeighScore55.8/10061.3/100
GradeCC
Scorecard rank#430#296
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Beluga Health

Graded #430 · C

Strengths

  • Supports GLP-1 care with compounded semaglutide and tirzepatide
  • Board-certified providers and a 50-state medical infrastructure
  • LegitScript certified with SOC 2 and ISO 27001 security
  • Pharmacies follow FDA/USP standards with third-party batch testing
  • Powers many DTC brands as a turnkey telehealth backbone

Where it loses points

  • White-label B2B group, not a direct consumer-facing service
  • Offers compounded, not FDA-approved branded, GLP-1s
  • No public consumer pricing for the GLP-1 offering
  • Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
  • Care quality varies by the consumer brand using the platform
BloomWell Rx

Graded #296 · C

Strengths

  • Transparent pricing — compounded semaglutide from $199/mo, tirzepatide (GLP-1/GIP) from $249/mo
  • Free initial visit; fully online process with flexible dosing options
  • Discloses meds are compounded by a licensed third-party pharmacy; also offers NAD+, sermorelin, glutathione
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)

Where it loses points

  • 'Starts at' pricing — final cost depends on dose and plan
  • Compounding pharmacy partner not named ('licensed third-party pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Operating medical entity not clearly named (site operated by a marketing agency)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard